Solutions from the
Real World
Type 1 diabetes.
For a researcher, it’s an enigma.
For an endocrinologist, it’s the job.
For you, it’s everyday life.
For T1D Exchange, it’s our mission.
We translate real-world experiences into real-world solutions that make your life easier.
LATEST NEWS
ANNUAL REPORT
Our 2018 Annual Report is now available! To read more about what T1D Exchange accomplished in 2018, click here.
FUELING RESEARCH
Several hundred participants take part in new effort to collect real-world data for type 1 diabetes research. Read more.
IN THE CLINIC
An interview with pediatric endocrinologist Dr. Mark Clements of Children’s Mercy Hospital in Kansas City. Dr. Clements sits on the IT subcommittee for the T1D Exchange Quality Improvement Collaborative. Read more.
INNOVATION
A father’s desire to keep his daughter safe at school leads to an algorithm to predict blood glucose trends for those who use multiple daily injections. Read more.
The T1D Exchange Registry is open for early enrollment
Be one of the first to add your voice,
experiences, and data to this research study.
OUR PARTNERS
The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional efforts in the United States and around the world in health and select place-based initiatives. We strive to make a meaningful impact in these areas, employing not only our significant financial assets, but also a rigorous, results-oriented approach and a keen understanding of relevant issues, needs, and opportunities.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D.
The American Diabetes Association’s mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
Abbott Diabetes Care is constantly working to deliver the highest quality products and unwavering support to their customers. Consistent and accurate glucose monitoring is the foundation of any diabetes management plan so we are committed to continuous improvement in the way patients and professionals measure, track and analyze glucose levels.
Bigfoot Biomedical is dedicated to making lives healthier, safer, and easier by enabling optimized insulin delivery solutions accessible for all.
Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring technology to help patients and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering our community to take control of diabetes.
Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a patient driven approach, we are working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.
Lilly unites caring with discovery to make life better for people around the world. We make medicines that help people live longer, healthier, more active lives.
Insulet Corporation is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform.
Sanofi is a global biopharmaceutical company committed to healthcare solutions from prevention to treatment. We turn scientific discoveries into medicine to improve human health. Every day we dedicate our most important resource, our people, to support patients and families through their health journey.
Tidepool is an open source, not-for-profit company focused on liberating data from diabetes devices, supporting researchers, and providing great, free software to people with diabetes and their care teams.
Xeris is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables.
Zealand Pharma is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other specialty disease areas with significant unmet medical needs.